Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Pharmacol ; 49(4): 519-28, 1995 Feb 14.
Article in English | MEDLINE | ID: mdl-7872957

ABSTRACT

A thrombin receptor has been described that is activated by thrombin cleavage generating a new N-terminus. The newly exposed SFLLR-containing "tethered-ligand" then activates the receptor. In these studies, we used 3-mercapto-propionyl-Phe-Cha-Cha-Arg-Lys-Pro-Asn- Asp-Lys-amide (Mpapeptide) as a thrombin receptor antagonist. This compound was capable of preventing both thrombin- and SFLLR-peptide-induced platelet aggregation with little effect on collagen-induced platelet aggregation. It also prevented thrombin- and SFLLRNP-induced calcium mobilization with little effect on thromboxane receptor-activated platelet Ca2+ mobilization. Platelet membrane GTPase could be activated by peptides that activated the thrombin receptor, and the thrombin receptor antagonist also prevented receptor-stimulated GTPase activity. Platelet phospholipase A2 (PLA2) activity (measured as the release of radiolabeled arachidonic acid) and Na+/H+ exchange activation were stimulated by alpha-thrombin and by SFLLR-containing peptides. Activation of both processes with low concentrations of thrombin required thrombin's anion-binding exosite, as they were not activated by similar concentrations of gamma-thrombin, and the alpha- and zeta-thrombin activation was blocked by peptides mimicking the C-terminal region of hirudin. Stimulation of PLA2 and Na+/H+ exchange by both thrombin and SFLLR-containing peptides was inhibited by the thrombin receptor antagonist Mpa-peptide. These results support the hypothesis that thrombin stimulation of PLA2 activity and Na+/H+ exchange occurs via activation of the thrombin tethered-ligand receptor. Moreover, these data are consistent with the tethered-ligand receptor mediating most actions elicited by low concentrations of alpha-thrombin involved in human platelet activation.


Subject(s)
Oligopeptides/antagonists & inhibitors , Phospholipases A/antagonists & inhibitors , Platelet Activation/drug effects , Platelet Aggregation/drug effects , Receptors, Thrombin/antagonists & inhibitors , Sodium-Hydrogen Exchangers/antagonists & inhibitors , Thrombin/antagonists & inhibitors , Adenylyl Cyclase Inhibitors , Amino Acid Sequence , Blood Platelets/metabolism , Humans , Molecular Sequence Data , Oligopeptides/pharmacology , Phospholipases A2 , Platelet Aggregation Inhibitors/pharmacology
2.
Int J Pept Protein Res ; 45(2): 145-51, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7782162

ABSTRACT

Proteolytic action of alpha-thrombin on human thrombin receptor results in cleavage of a portion of the N-terminus, thereby generating a 'tethered ligand' at the newly exposed N-terminus, which then activates the receptor in an intramolecular fashion. Agonist peptides incorporating the amino acid sequence of the newly exposed N-terminal portion of the cleaved receptor cause receptor activation without requiring prior cleavage of the receptor by thrombin. The pentapeptide amide Ser-Phe-Leu-Leu-Arg-NH2, which retains the N-terminal sequence of the 'tethered ligand' of the receptor, has been shown to be the minimum sequence to cause receptor activation. To understand the importance of the side chains of various residues within the pentapeptide amide, we carried out an extensive structure-activity study of the ability of peptides to stimulate gel-filtered platelet aggregation. In this study 106 pentapeptide amides were synthesized, utilizing naturally occurring L-amino acids, unnatural amino acids, D-amino acids and N-methyl amino acids for replacements. At position-1, charged residues (acidic or basic) were not tolerated, and the size and shape of the residue were important. Position-2 tolerated only aromatic residues. Position-3 accommodated various residues. A significant finding of this study was that two very different residues, [3-(2-naphthyl)]-L-alanine and L-arginine, when substituted for leucine residue at position-3, resulted in more active agonists. At position-4 aromatic and aliphatic residues were well tolerated, whereas basic and acidic residues were less tolerated. Position-5 mimicked position-3 in its ability to tolerate a wide range of residues.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Blood Platelets/drug effects , GTP Phosphohydrolases/metabolism , Oligopeptides/chemistry , Oligopeptides/pharmacology , Platelet Aggregation/drug effects , Receptors, Thrombin/agonists , Amino Acid Sequence , Binding Sites , Blood Platelets/enzymology , Blood Platelets/physiology , Humans , Ligands , Molecular Sequence Data , Oligopeptides/chemical synthesis , Structure-Activity Relationship , Thrombin/metabolism
3.
J Biol Chem ; 268(34): 25449-54, 1993 Dec 05.
Article in English | MEDLINE | ID: mdl-8244978

ABSTRACT

Herpes simplex virus type-1 (HSV-1) protease is responsible for proteolytic processing of itself and the virus assembly protein ICP35 (infected cell protein 35). Two proteolytic processing sites within the protease have recently been identified between Ala247 and Ser248 and between Ala610 and Ser611. In this report we demonstrate that peptides corresponding to each of these cleavage sites are substrates for recombinant HSV protease-glutathione S-transferase fusion protein in vitro by high performance liquid chromatography analysis of cleavage reactions. Analysis of the products by fast atom bombardment-mass spectrometry confirmed that cleavage occurred at the expected position between the Ala and Ser residues of the substrate. Peptide cleavage was linear with respect to time and enzyme concentration and proceeded optimally at pH 8.0. A peptide that spans Ala99/Ser100 of the protease but does not correspond to a naturally occurring cleavage site was not a substrate for the protease in vitro confirming that sequence elements outside the conserved dipeptide sequence are required for substrate recognition and cleavage. Identification of P5-P8' as the minimal substrate peptide for the Ala610/Ser611 cleavage site revealed a requirement for residues flanking the conserved core P4-LVNA/S-P1' in substrate recognition and hydrolysis. Kinetic analysis with peptide P5-P8' yielded a Km of 190 microM and kcat of 0.2 min-1. Experiments with a panel of class-specific protease inhibitors were consistent with the protease being a member of the general class of serine proteases.


Subject(s)
Endopeptidases/metabolism , Herpesvirus 1, Human/enzymology , Amino Acid Sequence , Binding Sites , Chromatography, High Pressure Liquid , DNA-Binding Proteins/biosynthesis , Endopeptidases/biosynthesis , Kinetics , Molecular Sequence Data , Peptides/chemical synthesis , Peptides/isolation & purification , Peptides/metabolism , Protease Inhibitors/pharmacology , Protein Processing, Post-Translational , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Substrate Specificity , Viral Proteins/biosynthesis
4.
Int J Pept Protein Res ; 42(5): 484-9, 1993 Nov.
Article in English | MEDLINE | ID: mdl-7508899

ABSTRACT

The selectins are a family of three structurally related glycoproteins that are integral components of leukocyte adhesion to the vascular endothelium. Their involvement in the recruitment and extravasation of neutrophils is critical in mounting an inflammatory reaction. The carbohydrate nature of the selectin ligands suggests that the binding regions of the selectins are contained within the lectin-like domains of the selectins. The synthesis and evaluation for inhibition of selectin binding of overlapping peptides of the lectin and adjacent EGF-like domains of P-selectin have been used to identify small peptides that completely inhibit P-selectin-dependent neutrophil adhesion. These peptides span a region of more than 100 amino acids and may define the carbohydrate recognition domain of P-selectin.


Subject(s)
Antigens, CD , Lectins/chemistry , Neutrophils/drug effects , Peptides/chemistry , Platelet Membrane Glycoproteins/chemistry , Protein Structure, Tertiary , Amino Acid Sequence , Carbohydrates/chemistry , Epidermal Growth Factor/chemistry , Humans , Leukocyte Adherence Inhibition Test , Molecular Sequence Data , P-Selectin
5.
Eur J Nucl Med ; 17(6-8): 305-9, 1990.
Article in English | MEDLINE | ID: mdl-2286203

ABSTRACT

Electrostatic effects play an important role in protein interactions and may alter the biodistribution of antibodies. To study the effect of molecular charge of the biodistribution and infection imaging properties of human polyclonal immunoglobulin G (IgG), its isoelectric point was varied by changing the level of diethylene triamine penta-acetic acid (DTPA) substitution: 0.8, 0.9, 3.7, 5.1 and 5.9 DTPA/IgG. Biodistributions of the different IgG preparations were determined at 10 min, 1, 6, 24, and 48 h post injection in normal rats, and infection imaging properties were determined in rats with Escherichia coli thigh infections. The biodistribution was significantly affected by pI. The immunoglobulin preparations with 0.9 and 3.7 DTPA/IgG showed faster clearance from the circulation and generally lower accumulation in most organs. The images had a target-to-background ratio of approximately 1.3-2.3:1. These results suggest that even though targeting is not affected by the level of DTPA substitutions, preparations with 0.9 and 3.7 DTPA/IgG may be superior imaging agents because of reduced accumulation by background organs.


Subject(s)
Immunoglobulin G , Indium Radioisotopes , Animals , Escherichia coli Infections/diagnostic imaging , Focal Infection/diagnostic imaging , Humans , Isoelectric Point , Male , Pentetic Acid , Radionuclide Imaging , Rats , Rats, Inbred Strains , Thigh , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...